Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Asgard Therapeutics AB
BioCentury | Sep 19, 2024
Discovery & Translation
Science Spotlight: Cancer prognosis via deep learning, new protein degraders, and more
BioCentury’s roundup of translational innovations
BioCentury | Mar 14, 2024
Finance
Venture Report: Tubulis’ big B round to advance ADCs, Relation adds to seed financing
Plus new rounds for Mission, Asgard and more
BioCentury | Nov 10, 2021
Product Development
Nov. 9 Quick Takes: Arbor’s $215M round attracts Temasek, Ally Bridge, TCG
Janssen trims Alkermes deal, EU moves to standardize HTA, plus GE Healthcare, Biogen, Amylyx and more
Items per page:
1 - 3 of 3